v3.25.4
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2023   235,777,000        
Beginning balance at Jan. 31, 2023 $ 1,487,434 $ 118 $ 2,642,022 $ (1,177,480) $ (1,019) $ 23,793
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   1,146,000        
Issuance of common stock upon exercise of options 8,695 $ 2 8,693      
Issuance of common stock under RSU and PSU release (in shares)   4,041,000        
Issuance of common stock under RSU and PSU release 0          
Issuance of common stock under employee stock purchase plan (in shares)   747,000        
Issuance of common stock under employee stock purchase plan 76,375 $ 1 76,374      
Issuance of common stock for restricted stock awards (in shares)   125,000        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   27,000        
Issuance of common stock for founders holdbacks related to acquisitions $ 4,314   4,314      
Issuance of common stock for payment of board of director fees (in shares) 2,000          
Issuance of common stock for payment of board of director fees $ 344   344      
Stock-based compensation expense, net of founder revest 644,007   644,007      
Capitalized stock-based compensation 34,385   34,385      
Fair value of replacement equity awards attributable to pre-acquisition service 652   652      
Net income (loss) 73,439     72,181   1,258
Non-controlling interest 8,088         8,088
Other comprehensive income (loss) (644)       (644)  
Ending balance (in shares) at Jan. 31, 2024   241,865,000        
Ending balance at Jan. 31, 2024 2,337,089 $ 121 3,410,791 (1,105,299) (1,663) 33,139
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   514,000        
Issuance of common stock upon exercise of options 3,983   3,983      
Issuance of common stock under RSU and PSU release (in shares)   4,552,000        
Issuance of common stock under RSU and PSU release 0 $ 3 (3)      
Issuance of common stock under employee stock purchase plan (in shares)   858,000        
Issuance of common stock under employee stock purchase plan 99,616   99,616      
Issuance of common stock for restricted stock awards (in shares)   72,000        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   11,000        
Issuance of common stock for founders holdbacks related to acquisitions 3,555   3,555      
Issuance of common stock for payment of board of director fees 348   348      
Stock-based compensation expense, net of founder revest 853,099   853,099      
Capitalized stock-based compensation 36,959   36,959      
Fair value of replacement equity awards attributable to pre-acquisition service 1,155   1,155      
Net income (loss) (12,566)     (15,241)   2,675
Non-controlling interest 3,609         3,609
Other comprehensive income (loss) (7,930)       (7,930)  
Ending balance (in shares) at Jan. 31, 2025   247,872,000        
Ending balance at Jan. 31, 2025 $ 3,318,917 $ 124 4,409,503 (1,120,540) (9,593) 39,423
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares) 359,000 359,000        
Issuance of common stock upon exercise of options $ 3,163   3,163      
Issuance of common stock under RSU and PSU release (in shares)   4,646,000        
Issuance of common stock under RSU and PSU release 0 $ 3 (3)      
Issuance of common stock under employee stock purchase plan (in shares)   440,000        
Issuance of common stock under employee stock purchase plan 125,834   125,834      
Issuance of common stock for restricted stock awards (in shares)   26,000        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   20,000        
Issuance of common stock for founders holdbacks related to acquisitions 9,204   9,204      
Issuance of common stock for payment of board of director fees 375   375      
Stock-based compensation expense, net of founder revest 1,086,346   1,086,346      
Capitalized stock-based compensation 57,825   57,825      
Fair value of replacement equity awards attributable to pre-acquisition service 2,302   2,302      
Net income (loss) (161,165)     (162,502)   1,337
Non-controlling interest 3,455         3,455
Other comprehensive income (loss) 26,349       26,349  
Ending balance (in shares) at Jan. 31, 2026   253,363,000        
Ending balance at Jan. 31, 2026 $ 4,472,605 $ 127 $ 5,694,549 $ (1,283,042) $ 16,756 $ 44,215